Identification of the stereochemical requirements in the 4-aryl-2-cycloalkylidenhydrazinylthiazole scaffold for the design of selective human monoamine oxidase B inhibitors.

MLA

D, Ascenzio, Melissa, et al. “Identification of the Stereochemical Requirements in the 4-Aryl-2-Cycloalkylidenhydrazinylthiazole Scaffold for the Design of Selective Human Monoamine Oxidase B Inhibitors.” Bioorganic & Medicinal Chemistry, vol. 22, no. 10, May 2014, pp. 2887–95. EBSCOhost, https://doi.org/10.1016/j.bmc.2014.03.042.

APA

D, A. M., Carradori, S., Secci, D., Mannina, L., Sobolev, A. P., De Monte, C., Cirilli, R., Yáñez, M., Alcaro, S., & Ortuso, F. (2014). Identification of the stereochemical requirements in the 4-aryl-2-cycloalkylidenhydrazinylthiazole scaffold for the design of selective human monoamine oxidase B inhibitors. Bioorganic & Medicinal Chemistry, 22(10), 2887–2895. https://doi.org/10.1016/j.bmc.2014.03.042

Chicago

D, Ascenzio, Melissa, Simone Carradori, Daniela Secci, Luisa Mannina, Anatoly P. Sobolev, Celeste De Monte, Roberto Cirilli, Matilde Yáñez, Stefano Alcaro, and Francesco Ortuso. 2014. “Identification of the Stereochemical Requirements in the 4-Aryl-2-Cycloalkylidenhydrazinylthiazole Scaffold for the Design of Selective Human Monoamine Oxidase B Inhibitors.” Bioorganic & Medicinal Chemistry 22 (10): 2887–95. doi:10.1016/j.bmc.2014.03.042.